宣肺清气法治疗老年肺炎的研究
|
摘要
老年肺炎是老年人呼吸系统常见病、多发病,其发病率和病死率往往随年龄增高而增高,病情随年龄增长而加重。鉴于本病人群的特殊性和病情的复杂性,加之现代社会老年人群的逐渐增多,老年肺炎已经成为临床呼吸系统最为常见的疾病之一。在西医治疗效果不理想的情况下,采用中西医结合的方法就显得尤为重要。根据本病的临床特征,应属温病肺热证的范畴。为了寻求临床更好的中医治疗方法,本研究在中医温病学理论指导下,对宣肺清气法的临床运用进行了理论、临床和相关的实验研究。
本研究主要分为四部分,第一部分为文献综述,主要对国内外中医和西医治疗老年肺炎的研究成果进行综述。现代医学在未获得病原体和药敏结果前,主要根据院内外细菌感染的规律,经验型选用具有强力杀菌作用的抗生素控制感染,多主张联合用药。多数学者认为,虽然临床有抗生素和多种支持疗法的综合治疗,但由于老年肺炎患病率高、病情进展快、临床症状多不典型、漏诊率高、并发症多、临床症状缓解慢、涉及病种较多,加之老年人体质特殊和基础疾病多等特点,治疗效果仍不能令人满意。认为老年肺炎的发生主要有两个方面,一为正气不足,一为温邪袭肺；初期和中期的临床表现多以痰、热、咳、喘、气急等气分症状为主,多以邪热壅肺、肺气郁闭为病机,治疗应主要针对肺热,同时也要兼顾肺闭,既要清解气分邪热,也要宣肺开闭。中医药治疗老年肺炎具有一定优势,宣肺清气法在清解肺热的同时兼顾宣肺开闭,在临床应用上获得了明显的效果,所以有必要对宣肺清气法治疗老年肺炎的机理进行深入研究。
第二部分主要对老年肺炎的有关理论进行研究,认为虚、痰、郁、瘀交织是老年肺炎的体质特征,并且贯穿于病程的始终。肺热炽盛、体虚邪实是老年肺炎的病机特点；热邪伤正,肺络闭阻是老年肺炎发生变证的主要原因,可出现心阳暴脱、邪陷心包、化源欲绝、肺脏痿弱等险恶证候。由于本病肺热炽盛、郁闭于内是病情发展的重要原因,因而提出：宣肺清气法是治疗老年肺炎的重要方法。宣肺清气法是指在清解气分邪热中有机的配合轻清宣畅肺气的药物,使肺经邪热宣泄而出的治疗方法。该法既能宣畅肺气使邪热透达外解,又能清泄肺热避免邪热内郁生变,在本病早、中期邪在气分时使用可以取得良好疗效。运用宣肺清气法治疗老年肺炎的基本原则是明确主症、把握病程,其中以肺热炽盛为辨证要点,以病程初、中期为常用阶段。同时,立足主法、灵活变化也是正确应用该法的关键,要考虑到老年患者的特殊体质和病程中的兼夹因素,随证加减或适当配合其它治疗方法,如化痰止咳、降气平喘、活血化瘀、益气养阴、润燥通下、清营凉血等,方能尽快控制肺部炎症,促进机体康复。
第三部分为临床研究,选择江苏省中医院呼吸科60例老年社区获得性肺炎住院病人,按照随机、对照原则,分为治疗组和对照组各30例。对照组给予西医常规治疗(包括一般治疗、对症治疗和抗生素治疗),治疗组在对照组治疗的基础上同时给予中药宣肺清气方。试验结果：(1)疾病疗效比较：在治愈率、显效率和有效率的具体数值上,治疗组均高于对照组,但两组各率的比较在统计学上均无显著性差异,疗效相当。(2)证候疗效比较显示,治疗组明显优于对照组。两组显效率比较,具有明显差异,治疗组明显优于对照组。(3)单项症状体征比较：治疗组在缓解发热、恶寒、咳嗽、咳痰和舌质方面未见明显的优势,但对于退热时间、脉象和肺部啰音的改善情况,治疗组有着明显的优势。(4)两组血清WBC、N、CRP水平在治疗后均有显著下降,但两组治疗后的差值比较无统计学意义；对照组治疗前后ESR无显著差异,但治疗组治疗前后ESR有显著差异,两组治疗前后的差值比较亦有显著差异,治疗组明显优于对照组。试验结果表明,宣肺清气方在缓解症状、改善体征、缩短退热时间和改善肺部啰音等方面具有一定优势。
第四部分为实验研究。为了进一步研究宣肺清气法的作用机理和预防由肺炎引发的肺纤维化的作用,进行了以下实验研究：(1)宣肺清气方对博莱霉素致大鼠肺损伤和死亡保护率的影响。结果发现,该方能降低肺损伤的程度,抑制肺指数的升高,在肺损伤早期具有明显的死亡保护作用。表明宣肺清气方具有宣肺祛邪,抑制炎症反应和保护肺脏的作用。(2)宣肺清气方对肺损伤大鼠免疫功能的影响,实验观察到该方能够降低博莱霉素诱发肺损伤大鼠TNF-α、IFN-γ、IL-4的水平。表明该方的作用机制之一,可能是通过影响炎症因子及抗感染免疫相关因子,达到治疗急性肺损伤和防止肺纤维化的目的。(3)宣肺清气方对博莱霉素致大鼠肺纤维化的干预作用。研究表明,宣肺清气方能够降低博莱霉素诱发大鼠肺泡炎和肺间质纤维化程度。(4)宣肺清气方对肺纤维化大鼠ERK1/2和NF-κB信号通路的影响。结果提示,该方能明显降低模型大鼠肺组织ERK1／2和NF-κB水平,与模型组有显著差异。表明宣肺清气方预防和治疗肺纤维化的作用机制之一,可能与干预ERK1／2和NF-κB等信号通路的激活有关。
总之,论文从文献、理论、临床、实验四个方面研究了宣肺清气法治疗老年肺炎的有关问题,初步阐明了该法的作用机理。其研究结果,不仅可为临床治疗老年肺炎提供中医理论指导,也为今后进一步的理论研究和临床、实验研究奠定了良好基础。
Pneumonia in elderly, a common and frequently-occurring respiratory disease, has increasing morbidity, mortality and severity with aging. Because of specificity of the affected population, complexity of the disease and the growth of the aged population, pneumonia in elderly is one of the most common respiratory diseases.Combined treatment of Chinese medicine with modern medicine is salient while modern medicine has dissatisfactory treatment.According to clinical characteristics, this disease could be put under the category of febrile diseases. For the sake of better TCM treatment, under the guidance of the theory of febrile diseases, clinical application of Declaring Lung and Eliminating Qi is discussed from the aspects of theory research, clinical observation and experiments.
The research is divided into 4 parts. The first part, literature reviews, mainly reviews the achievements of domestic and overseas research on treatment of pneumonia in elderly by Chinese medicine and modern medicine. Western medicine chooses potent antibiotics and comprehensive treatments according to bacterial infection rule in hospitals and in communities, before the results of pathogens and susceptibility test come out. Most scholars suggest that all the above treatments can not generate effects because of the high rate of infections, fast progress, atypical clinical symptoms, high rate of missed diagnosis, many complications, slow clinical remission, many related diseases, specificity of the aged and their basic diseases. The reasons of occurrence of pneumonia in elderly include weak resistibility and febrile evils invading lung. The initial stage and intermediate stage are manifested with sputum, heat, cough, wheezing and dyspnea. The pathogenesis is accumulation of pathogenic heat in the lung and failure of lung qi in dispersion. Treatment of Declaring Lung and Eliminating Qi focuses on relieving lung-heat and dispersion failure. TCM has advantages in treatment of pneumonia in elderly. Therefore, study of the mechanism of such law should be furthered.
The second part mainly studies TCM theories of pneumonia in elderly. Intertwining of deficiency, phlegm, depression and stagnation is the constitutional characteristic of pneumonia in elderly. Exuberant lung-heat, physically weakness and evil pathogens are its pathogenesis. Heat evils damaging vital qi and closure of lung collaterals are the main reasons of deteriorated cases, causing sudden depletion of heart yang, invasion of cardial sac by pathogen, breathing failure and lung atrophy. So, the law of Declaring Lung and Eliminating Qi is an important treatment of pneumonia in elderly. The law refers to combination of drugs of ventilating lung qi when clearing heat at qi, to dispel lung heat and avoid the stagnation of evil heat. There is an obvious effect at the initial stage and intermediate stage. The basic application principle of Declaring Lung and Eliminating Qi is identifying main syndromes and grasping disease courses. Exuberant lung-heat is a key symptom differentiation. At the same time, the special physic constitution and other factors should be taken into account. Other treatment methods, such as eliminating sputum and reliving cough, lowing qi to dispel asthma, promoting blood circulation to remove blood stasis, nourishing qi and yin, moistening dryness and catharsis, and cooling yingfen and blood, should be combined to control lung infection as soon as possible to promote recovery.
In partⅢ,clinical research,60 cases of conformed senile CAP from Chinese Medicine Hospital of Jiangsu Province were randomly divided into a control group (30 cases), treated with general treatment and anti-infective therapy, and a treatment group (30 cases), treated with Ventilating-lung-qi and clearing-heat Formula, general treatment and anti-infective therapy.
Results:(1) There is no statistically significant difference between two groups in cure rate, marked effect and effective power, that is to say, the efficacy of two groups are equivalent.(2) The comparison of syndrome's effect shows that the effect of the treatment group was significantly better than that of the control group. Comparing the two groups markedly effective, there was with significant differences and significantly better than the control group. (3) Comparison of individual symptoms and signs:There is no obvious advantage in the treatment group in dealing with fever, aversion to cold, cough, sputum, and tongue. But there are advantages in fever time, pulse, and pulmonary rales.(4) The levels of serum WBC, N, CRP were significantly decreased after treatment, but the difference between the two groups was no of statistical significance. ESR level in the control group has no significant difference before and after treatment, but that of the treatment group has significant difference. The difference in the two groups before and after treatment is also significant The treatment group was significantly better than the control group. The results of clinical trial show that Ventilating-lung-qi and clearing-heat Formula has some advantages in relieving symptoms and signs, reducing fever time and improving pulmonary rales.
In part IV, experiments, to further study mechanism of the law of Declaring Lung and Eliminating Qi and prevention of pulmonary fibrosis caused by lung infections, the following experimental studies were carried out:(1) experiment of protecting acute lung injury and protection impact on death rates induced by bleomycin treated by Ventilating-lung-qi and clearing-heat Formula:the prescription can reduce the degree of acute lung injury, inhibit increase of lung index and has a significant protective effect in the early lung injury. The result shows that the prescription has the role of ventilating lung qi and eliminating evils, inhibiting inflammatory response and protecting lung. (2) experiment of the prescription in affecting immunity of acute lung injury in rats induced by bleomycin:the prescription can reduce the degrees of TNF-a, IFN-y, IL-4 levels of bleomycin-induced lung injury in rats. It shows that one mechanism of the prescription to treat acute lung injury and to prevent pulmonary fibrosis could be affecting inflammatory factors and anti-infection immune-related factors. (3) experiment of the prescription in interfering Bleomycin-induced pulmonary fibrosis in rats:the prescription can reduce the degree of bleomycin-induced pneumonia and pulmonary fibrosis.(4) experiment of the prescription in affecting ERK1/2 and NF-KB signal pathway of pulmonary fibrosis in rats:the results suggest that the prescription can significantly reduce the levels of ERK1/2 and NF-KB of lung tissues and has significantly difference compared with the model group. It shows that this is one of mechanisms of the prescription in treating acute lung injury and preventing pulmonary fibrosis via interfering with ERKl/2 and NF-KB signal pathway.
In short, four parts above initially illustrate the mechanism. Its findings not only provide TCM theoretical guidance for clinical treatment of pneumonia in elderly, but also lay a good basis for further theoretical, clinical and experimental studies.
本研究主要分为四部分,第一部分为文献综述,主要对国内外中医和西医治疗老年肺炎的研究成果进行综述。现代医学在未获得病原体和药敏结果前,主要根据院内外细菌感染的规律,经验型选用具有强力杀菌作用的抗生素控制感染,多主张联合用药。多数学者认为,虽然临床有抗生素和多种支持疗法的综合治疗,但由于老年肺炎患病率高、病情进展快、临床症状多不典型、漏诊率高、并发症多、临床症状缓解慢、涉及病种较多,加之老年人体质特殊和基础疾病多等特点,治疗效果仍不能令人满意。认为老年肺炎的发生主要有两个方面,一为正气不足,一为温邪袭肺；初期和中期的临床表现多以痰、热、咳、喘、气急等气分症状为主,多以邪热壅肺、肺气郁闭为病机,治疗应主要针对肺热,同时也要兼顾肺闭,既要清解气分邪热,也要宣肺开闭。中医药治疗老年肺炎具有一定优势,宣肺清气法在清解肺热的同时兼顾宣肺开闭,在临床应用上获得了明显的效果,所以有必要对宣肺清气法治疗老年肺炎的机理进行深入研究。
第二部分主要对老年肺炎的有关理论进行研究,认为虚、痰、郁、瘀交织是老年肺炎的体质特征,并且贯穿于病程的始终。肺热炽盛、体虚邪实是老年肺炎的病机特点；热邪伤正,肺络闭阻是老年肺炎发生变证的主要原因,可出现心阳暴脱、邪陷心包、化源欲绝、肺脏痿弱等险恶证候。由于本病肺热炽盛、郁闭于内是病情发展的重要原因,因而提出：宣肺清气法是治疗老年肺炎的重要方法。宣肺清气法是指在清解气分邪热中有机的配合轻清宣畅肺气的药物,使肺经邪热宣泄而出的治疗方法。该法既能宣畅肺气使邪热透达外解,又能清泄肺热避免邪热内郁生变,在本病早、中期邪在气分时使用可以取得良好疗效。运用宣肺清气法治疗老年肺炎的基本原则是明确主症、把握病程,其中以肺热炽盛为辨证要点,以病程初、中期为常用阶段。同时,立足主法、灵活变化也是正确应用该法的关键,要考虑到老年患者的特殊体质和病程中的兼夹因素,随证加减或适当配合其它治疗方法,如化痰止咳、降气平喘、活血化瘀、益气养阴、润燥通下、清营凉血等,方能尽快控制肺部炎症,促进机体康复。
第三部分为临床研究,选择江苏省中医院呼吸科60例老年社区获得性肺炎住院病人,按照随机、对照原则,分为治疗组和对照组各30例。对照组给予西医常规治疗(包括一般治疗、对症治疗和抗生素治疗),治疗组在对照组治疗的基础上同时给予中药宣肺清气方。试验结果：(1)疾病疗效比较：在治愈率、显效率和有效率的具体数值上,治疗组均高于对照组,但两组各率的比较在统计学上均无显著性差异,疗效相当。(2)证候疗效比较显示,治疗组明显优于对照组。两组显效率比较,具有明显差异,治疗组明显优于对照组。(3)单项症状体征比较：治疗组在缓解发热、恶寒、咳嗽、咳痰和舌质方面未见明显的优势,但对于退热时间、脉象和肺部啰音的改善情况,治疗组有着明显的优势。(4)两组血清WBC、N、CRP水平在治疗后均有显著下降,但两组治疗后的差值比较无统计学意义；对照组治疗前后ESR无显著差异,但治疗组治疗前后ESR有显著差异,两组治疗前后的差值比较亦有显著差异,治疗组明显优于对照组。试验结果表明,宣肺清气方在缓解症状、改善体征、缩短退热时间和改善肺部啰音等方面具有一定优势。
第四部分为实验研究。为了进一步研究宣肺清气法的作用机理和预防由肺炎引发的肺纤维化的作用,进行了以下实验研究：(1)宣肺清气方对博莱霉素致大鼠肺损伤和死亡保护率的影响。结果发现,该方能降低肺损伤的程度,抑制肺指数的升高,在肺损伤早期具有明显的死亡保护作用。表明宣肺清气方具有宣肺祛邪,抑制炎症反应和保护肺脏的作用。(2)宣肺清气方对肺损伤大鼠免疫功能的影响,实验观察到该方能够降低博莱霉素诱发肺损伤大鼠TNF-α、IFN-γ、IL-4的水平。表明该方的作用机制之一,可能是通过影响炎症因子及抗感染免疫相关因子,达到治疗急性肺损伤和防止肺纤维化的目的。(3)宣肺清气方对博莱霉素致大鼠肺纤维化的干预作用。研究表明,宣肺清气方能够降低博莱霉素诱发大鼠肺泡炎和肺间质纤维化程度。(4)宣肺清气方对肺纤维化大鼠ERK1/2和NF-κB信号通路的影响。结果提示,该方能明显降低模型大鼠肺组织ERK1／2和NF-κB水平,与模型组有显著差异。表明宣肺清气方预防和治疗肺纤维化的作用机制之一,可能与干预ERK1／2和NF-κB等信号通路的激活有关。
总之,论文从文献、理论、临床、实验四个方面研究了宣肺清气法治疗老年肺炎的有关问题,初步阐明了该法的作用机理。其研究结果,不仅可为临床治疗老年肺炎提供中医理论指导,也为今后进一步的理论研究和临床、实验研究奠定了良好基础。
Pneumonia in elderly, a common and frequently-occurring respiratory disease, has increasing morbidity, mortality and severity with aging. Because of specificity of the affected population, complexity of the disease and the growth of the aged population, pneumonia in elderly is one of the most common respiratory diseases.Combined treatment of Chinese medicine with modern medicine is salient while modern medicine has dissatisfactory treatment.According to clinical characteristics, this disease could be put under the category of febrile diseases. For the sake of better TCM treatment, under the guidance of the theory of febrile diseases, clinical application of Declaring Lung and Eliminating Qi is discussed from the aspects of theory research, clinical observation and experiments.
The research is divided into 4 parts. The first part, literature reviews, mainly reviews the achievements of domestic and overseas research on treatment of pneumonia in elderly by Chinese medicine and modern medicine. Western medicine chooses potent antibiotics and comprehensive treatments according to bacterial infection rule in hospitals and in communities, before the results of pathogens and susceptibility test come out. Most scholars suggest that all the above treatments can not generate effects because of the high rate of infections, fast progress, atypical clinical symptoms, high rate of missed diagnosis, many complications, slow clinical remission, many related diseases, specificity of the aged and their basic diseases. The reasons of occurrence of pneumonia in elderly include weak resistibility and febrile evils invading lung. The initial stage and intermediate stage are manifested with sputum, heat, cough, wheezing and dyspnea. The pathogenesis is accumulation of pathogenic heat in the lung and failure of lung qi in dispersion. Treatment of Declaring Lung and Eliminating Qi focuses on relieving lung-heat and dispersion failure. TCM has advantages in treatment of pneumonia in elderly. Therefore, study of the mechanism of such law should be furthered.
The second part mainly studies TCM theories of pneumonia in elderly. Intertwining of deficiency, phlegm, depression and stagnation is the constitutional characteristic of pneumonia in elderly. Exuberant lung-heat, physically weakness and evil pathogens are its pathogenesis. Heat evils damaging vital qi and closure of lung collaterals are the main reasons of deteriorated cases, causing sudden depletion of heart yang, invasion of cardial sac by pathogen, breathing failure and lung atrophy. So, the law of Declaring Lung and Eliminating Qi is an important treatment of pneumonia in elderly. The law refers to combination of drugs of ventilating lung qi when clearing heat at qi, to dispel lung heat and avoid the stagnation of evil heat. There is an obvious effect at the initial stage and intermediate stage. The basic application principle of Declaring Lung and Eliminating Qi is identifying main syndromes and grasping disease courses. Exuberant lung-heat is a key symptom differentiation. At the same time, the special physic constitution and other factors should be taken into account. Other treatment methods, such as eliminating sputum and reliving cough, lowing qi to dispel asthma, promoting blood circulation to remove blood stasis, nourishing qi and yin, moistening dryness and catharsis, and cooling yingfen and blood, should be combined to control lung infection as soon as possible to promote recovery.
In partⅢ,clinical research,60 cases of conformed senile CAP from Chinese Medicine Hospital of Jiangsu Province were randomly divided into a control group (30 cases), treated with general treatment and anti-infective therapy, and a treatment group (30 cases), treated with Ventilating-lung-qi and clearing-heat Formula, general treatment and anti-infective therapy.
Results:(1) There is no statistically significant difference between two groups in cure rate, marked effect and effective power, that is to say, the efficacy of two groups are equivalent.(2) The comparison of syndrome's effect shows that the effect of the treatment group was significantly better than that of the control group. Comparing the two groups markedly effective, there was with significant differences and significantly better than the control group. (3) Comparison of individual symptoms and signs:There is no obvious advantage in the treatment group in dealing with fever, aversion to cold, cough, sputum, and tongue. But there are advantages in fever time, pulse, and pulmonary rales.(4) The levels of serum WBC, N, CRP were significantly decreased after treatment, but the difference between the two groups was no of statistical significance. ESR level in the control group has no significant difference before and after treatment, but that of the treatment group has significant difference. The difference in the two groups before and after treatment is also significant The treatment group was significantly better than the control group. The results of clinical trial show that Ventilating-lung-qi and clearing-heat Formula has some advantages in relieving symptoms and signs, reducing fever time and improving pulmonary rales.
In part IV, experiments, to further study mechanism of the law of Declaring Lung and Eliminating Qi and prevention of pulmonary fibrosis caused by lung infections, the following experimental studies were carried out:(1) experiment of protecting acute lung injury and protection impact on death rates induced by bleomycin treated by Ventilating-lung-qi and clearing-heat Formula:the prescription can reduce the degree of acute lung injury, inhibit increase of lung index and has a significant protective effect in the early lung injury. The result shows that the prescription has the role of ventilating lung qi and eliminating evils, inhibiting inflammatory response and protecting lung. (2) experiment of the prescription in affecting immunity of acute lung injury in rats induced by bleomycin:the prescription can reduce the degrees of TNF-a, IFN-y, IL-4 levels of bleomycin-induced lung injury in rats. It shows that one mechanism of the prescription to treat acute lung injury and to prevent pulmonary fibrosis could be affecting inflammatory factors and anti-infection immune-related factors. (3) experiment of the prescription in interfering Bleomycin-induced pulmonary fibrosis in rats:the prescription can reduce the degree of bleomycin-induced pneumonia and pulmonary fibrosis.(4) experiment of the prescription in affecting ERK1/2 and NF-KB signal pathway of pulmonary fibrosis in rats:the results suggest that the prescription can significantly reduce the levels of ERK1/2 and NF-KB of lung tissues and has significantly difference compared with the model group. It shows that this is one of mechanisms of the prescription in treating acute lung injury and preventing pulmonary fibrosis via interfering with ERKl/2 and NF-KB signal pathway.
In short, four parts above initially illustrate the mechanism. Its findings not only provide TCM theoretical guidance for clinical treatment of pneumonia in elderly, but also lay a good basis for further theoretical, clinical and experimental studies.
引文
1.孙铁英.老年肺炎的特点及危害[J].中华老年多器官疾病杂志,2005,1(4)：76-78
2. Riqueleme R, Torres A, ElEbiary M, et al.Commuinity Acquired pneumonia in the elderly:a multivariate analysis Of Risk and prognostic factors[J]. Am. J. Respir. Crit. Care. Med,1996,154: 14502-14505
3. Marrie TJ, Blanchard W. Acomparison of nursing home Acquired pneumonia and nursing home patients without pneumonia[J]J Am Geriatr Soc,1997,45:50-551
4.陈灏珠.实用内科学第12版[M].北京：人民卫生出版社：2005：1672-1674
5.张清,郑艳,郑承铎等.加味麻杏石甘汤治疗老年肺炎48例[J].现代医药卫生,2005,21(13)：1171-1172
6.王守富.中医药治疗老年肺炎的思路与方法[J].中医研究,2008,21(3)：10-12
7.万毅,黄坤强,苏博.中西医结合诊治老年肺炎相关问题的思考[J].北京中医药大学学报(中医临床版),2008,15(1)：44-46
8.孙业敏,魏蕾,郑林.中西医结合治疗老年肺炎77例[J].山东中医杂志,2005,24(4)：232-233
9.王丰.清肺汤治疗老年肺炎69例[J].实用中医内科杂志,2008,22(7)：25
10.郭琳.清肺养阴汤治疗老年肺炎60例临床观察[J].吉林中医药,2008,28(4)：270
11.崔巍.老年肺炎的中医治疗体会[J].中国社区医师,2006,8(16)：71
12.殷凯生.老年社区获得性肺炎诊断与治疗[J].实用老年医学,2004,18(1)：7-10
13.李茹,宫晓燕.青蒿鳖甲汤治疗老年社区获得性肺炎30例疗效观察[J].长春中医药大学学报,2008,24(3)：297
14.刘君英,刘鹏鹰.老年2型糖尿病患者合并肺炎的临床分析[J].医学研究杂志,2008,37(1)：86-88
15.王秀香,杨敬平,卜宝英.老年COPD并社区获得性肺炎常见病原菌及耐药性分析[J].临床肺科杂志,2008,13(4)：426-427
16.李国梁.不同宿疾罹患老年风温肺热病后传变特点探讨[J].中国中医基础医学杂志,2008,14(10)：786-787
17.王洋,王裕颐.中西医结合治疗老年肺炎思路探讨指导[J].光明中医,2005,20(3)：10-12
18.张清,郑艳,郑承铎.加味麻杏石甘汤治疗老年肺炎48例[J].现代医药卫生,2005,21(13)：1711-1712
19.符文明,从湿温论治老年真菌性肺炎38例[J].实用中西医结合临床,2008,8(1)：73-74
20.刘良丽,欧江琴,张葵等.清肺汤合参麦注射液治疗老年真菌肺炎25例[J].贵阳中医学院学报,2006,28(4)：11-12
21.朱均权.养阴清肺化痰汤治疗老年肺炎41例[J].江西中医药,2004,10(10)：29-30
22.李喜顺,洪永贵.益气清热法治疗老年肺炎的临床观察[J].光明中医,2007,22(10)：53-54
23.林军梅.扶正清肺汤治疗医院获得性老年肺炎33例临床观察[J].浙江中医杂志,2007,42(5)：268
24.李晓霞,李丽芳,薛华.参芪扶正注射液联合特定电磁波治疗老年肺炎临床分析[J].中国临床医生,2004,32(12)：36-37
25.欧江琴,周泽桂,刘良丽.参芪扶正注射液治疗老年肺炎临床观察[J].贵阳中医学院学报,2006,28(1)：27-28
26.崔健,鲍红荣.大蒜素注射液佐治社区获得性肺炎老年患者的疗效观察[J].中国现代应用药学杂志,2006,23(5)：423-425
27.叶玲,洪旭初,陈沁.灯盏细辛注射液佐治老年社区获得性肺炎36例[J].广东医学,2005,26(6)：862-863
28.姚亮,宋文宝,杨佩兰.黄芪注射液佐治老年肺炎疗效观察[J].河南中医,2004,24(11)：33-34
29.李淑云,洪渌.清开灵注射液治疗老年细菌性肺炎30例临床观察[J].中医药临床杂志,2004,16(4)：309-310
30.肖新建,曲立生.双黄连注射液为主治疗老年肺炎32例[J].中国中医急症,2008,17(4)：491
31.陈云凤,刘洪,扈晓宇.痰热清治疗老年社区获得性肺炎临床观察[J].中国中医急症,2006,15(6)：575-587
32.张杰敏,马汉伟.痰热清注射液对老年脑卒中并发肺炎的疗效观察[J].吉林医学学报,2005,26(12)：1336-1337
33.杨雪梅.痰热清注射液治疗老年肺炎36例[J].中国中医急症,2008,17(7)：990
34.贾建华.痰热清注射液治疗老年肺炎疗效观察[J].临床肺科杂志,2007,12(2)：135
35.潘英萍.鱼金注射液联合抗生素治疗老年肺炎疗效观察[J].实用中医药杂志,2006,22(8)：487
36.古立新,梁爱武,陈斯宁等.补肺片辅助治疗老年重症肺炎时的细胞免疫功能观察[J].医学文选,2006,25(4)：699-700
37.马培志,马利军,李建生.毒素清对老年肺炎患者免疫功能的影响[J].中国老年学杂志,2006,26(1)：119-120
38.管月帆.黄芪注射液辅助治疗老年肺炎时细胞免疫功能观察[J].中国老年保健医学杂志,2007,5(2)：41-42
39.姚亮,宋文宝,杨佩兰.黄芪注射液佐治老年肺炎疗效观察[J].河南中医,2004,24(11)：33-34
40.李玉英.细菌性肺炎的治疗进展[J].泸州医学院学报,2000,(5)：423
41.程克文,马佳韵,李明珠,张有志,周丽,付明明.老年人社区获得性肺炎临床分析[J].中国临床医学.2009,16(5)：722-724
42.李树强,115例老年肺炎临床分析[J].中国医药指南.2008,6(15)：235-236
43.闫晗,刘淑华,杜密稳等.王顺老年肺炎的危险因素与病原学特点及其治疗分析[J].中国临床药理学与治疗学.2009,14(1)：94-97
44.陆卫东,张斌,曲娜等.老年患者医院获得性肺炎菌群分类及耐药性分析[J].同济大学学报(医学版).2008,29(3)：104-107
45.李琼,彭喜松.258株铜绿假单胞菌耐药性分析[J].中国感染控制杂志,2007,6(3),53-54
46.汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5)：289-295
47.朱德妹,汪复,张婴元.2005年上海地区细菌耐药性监测[J].中国感染与化疗杂志,2006,6(6)：371-376
48.Wunderink RG, Rello J, Cammarata SK. et a.l Linezolidvs vancomycin analysis of two double-blind studies of patients with methicillin resistant Staphylococcus aureus nosocomial pneumonia [J]. Chest,2003, 124(5):1789-1797
49.胡必杰.实用内科学[M].北京：人民卫生出版社,2006
50.徐胜艳.老年肺部感染临床分析[J].中外医疗.2009,15：37
1.周文泉,李祥国主编[M].实用中医老年病学.人民卫生出版社：北京,2000：12-22
2.夏云阶,张韬玉,刘汴生,等.衰老与抗衰老学[M].北京：学苑出版社,2001：1-83
3.陈庆生,瞿唯凯.94例90岁以上健康老年人五脏功能的初步分析[J].浙江中医杂志,1987,20(2)：75
4.李凯利,王晓锋.老年科常见病的诊断与治疗[M].中国医药科技出版社：北京,1999：1-12
5.周文泉,李祥国主编.实用中医老年病学[M].人民卫生出版社：北京,2000：394-395；171-274
6.尚冰.从中医角度对肝与衰老关系的浅析[J].中医药学刊.2005,23(12)：2226-2227
7.王玉芳,路永超.试论肝与衰老的关系[J].山东中医药大学学报,2002,26(4)：249-251
8.盛增秀.王孟英医学全书·王孟英医案[M].北京：中国中医药出版社,1999：279
9.何廉臣.重订广温热论[M].北京：人民卫生出版社,1960：751
10.乔振纲,韩冠先主编.实用中医痰病证治[M].人民卫生出版社：北京,2001：9
11.曲妮妮.马智教授从痰论治肺系病证经验[J].中医药学刊,2006,24(1)：26-27
12.高岩.101例老年肺炎的临床特点与治疗体会[J].中国医药导报.2008,5(8)：117-118
13.陈林果,钟玉全.152例老年社区获得性肺炎临床特征分析[J].内蒙古中医药.2008,3：1-2
14.吕和平,任爱红,郝春杰等.老年人动态肺功能与衰老的关系[J].华北煤炭医学院学报,2005,7(1)：13-14
15.黄敏,夏向南.老年脑血管病并发肺部感染的防治[J].解放军保健医学杂志.2006,8(1)：40-41
16.吴济建,朱伟芬.老年痴呆后肺部感染中医和西医治疗的成本分析[J].现代中西医结合杂志.2008,17(28)：4419
17.刘君英,刘鹏鹰.老年2型糖尿病患者合并肺炎的临床分析[J].医学研究杂志.2008,37(1)：86-88
18.张茂林,张六通,邱幸凡.中医学衰老理论探讨[J].湖北中医杂志,2001,23(9)：9-11
19.王进,张羽中,邱少波.理论研究心藏象与衰老相关性研究[J].中医药信息.2006,23(6)：1-2
20.都全荣,曹忠义,杨佰华.老年慢性肺心病血液流变性改变与活血化瘀治疗效应临床研究[J].中国血液流变学杂志,2001,11(3)：242-245
21.许朝被,王忆勤.瘀血与肺相关论[J].新中医.2009,41(2)：7-8
22.郭利平SARS的中医药分期辨治[C].国家中医药管理局编,中医药防治SARS学术专辑,2003
23.贾彦焘.40例SARS症状观察与病机探讨[C].国家中医药管理局编,中医药防治SARS学术专辑,2003
24.王永炎.严重急性呼吸综合征证治浅析[C].国家中医药管理局编,中医药防治SARS学术专辑,2003
25.张伯礼.非典的中医病名、病机及治疗[C].国家中医药管理局编,中医药防治SARS学术专辑,2003
26.彭锦,刘洋.对SARS瘀阻肺络病机的探讨[J].中国中医基础医学杂志,2003,9(12)：16-17
27.苏峥.灯盏细辛注射液治疗肺系疾病血瘀型临床观察[J].广东医学,2003,24(1)：81
28.杨进.温病学[M].中国中医药出版社：北京2004：102
29.崔巍.老年性肺炎的中医治疗体会[J].中国社区医师.2006,8(16)：71
30.万毅,黄坤强,苏博.中西医结合诊治老年肺炎相关问题的思考[J].北京中医药大学学报(中医临床版),2008,15(1)：45-46
31.杨安林,路云霞.老年慢支合并肺炎的中医药治疗体会[J].中国社区医师.2008,10(184)：79-80
32.王仰宗,苏玲.热病理论在新发传染病中的应用—-人禽流感的辨证施治[J].中国中西医结合杂志,2007,20：3
33.徐金富,瞿介明,何礼贤.肺部感染相关急性肺损伤发病机制研究进展[J].国际呼吸杂志,2008,12
34.赵勤萍.肺间质纤维化中医证治探讨[J].山西中医学院学报,2005,6(1)：34-35
35.龚婕宁.中医药治疗肺间质纤维化的概况及展望[J].浙江中医杂志,1997,32(11)：483
36.龚婕宁.论肺纤维化与养肺活血法[J].中国中医基础医学杂志,2005,11(10)：759-761
37.李士懋,田淑霄.宣展气机解郁透邪为治疗温病之要义—学习赵绍琴老师阐发温病理论的心得[J].河南中医.1998,2：2-3
38.欧阳忠兴,柯新桥.中医呼吸病学[M].中国医药科技出版社.49
39.杨进.温病学[M].中国中医药出版社：北京.2004：103-110
40.唐彦,何平.蒲辅周辨治小儿腺病毒肺炎经验撷要[J],江苏中医药,2005,26(2)：13-14
41.王新华.历代医论精选[M].江苏：江苏科学技术出版社,1998：410
42.陆拯.近代中医珍本集·温热经纬[M].杭州：浙江科学技术出版社,1987：251
43.何廉臣.重订广温热论[M].北京：人民卫生出版社,1960：6
44.吴鞠通.温病条辨[M].北京：人民卫生出版社,1963：99
45.韩德军,王松.老年肺炎108例临床分析[J].中国现代医生.2009,47(15)：137-142
46.陈红,李小惠.老年肺炎临床特点分析[J].实用医院临床杂志.2008,5(6)：104-105
47.王守富.中医药治疗老年人肺炎的思路与方法[J].中医研究.2008,21(3)：10-12
48.于雪峰.清肺涤痰颗粒佐治老年吸入性肺炎35例临床分析[J].中国中医药信息杂志,2008,15(4)：77-78
49.中华医学会呼吸病学分会.社区获得性肺炎诊断和治疗指南[J].中华呼吸和结核杂志2006,29(10)：651-655
50.李忠。免疫中药学[M].郑州,河南医科大学出版社,1996：450
51.龚婕宁,王灿晖,沈凤阁.清肺活血法运用规律析要[J].江苏中医,1997,18(7)：28-29
52.王竹修.风温肺热病99例临床疗效观察[J].中医急症通讯,1988;(10)：8
53.黄英志.叶天士医学全书.临证指南医案[M].北京：中国中医药出版社,1999：44
54.郭琳,清肺养阴汤治疗老年肺炎60例临床观察[J].吉林中医药,2008,28(4)：270
55.何牧,宫晓燕.新宣白承气汤治疗风温肺热病的临床观察[J].长春中医药大学学报.2008,24(1)：75
56.谢恬,凌一揆.清瘟败毒饮对内毒素诱发家兔温病气血两燔证的疗效和机理[J].中国中西医结合杂志,1993,13(2)：94-97
57.江扬清主编.中西医结合内科研究[M].北京：北京出版社,1997：180
1.中华医学会呼吸病学分会.社区获得性肺炎诊断和治疗指南[J].中华呼吸和结核杂志,2006,29(10)：651-655
2.国家中医药管理局.中医病证诊断疗效标准[M].南京大学出版社.1994,6,28
3.杨进主编.温病学.人民卫生出版社
4.喻庆云,朱庄庄,曹云凯.老年人肺部感染的临床特点和治疗策略[J].中国老年保健医学杂志,2005,3(2)： 17-19
5.刘晓晴,黄骁燕,陈茹.综合医院住院老年肺炎临床特点的分析[J].中华老年医学杂志,2004,23(7)：510
6.陈娜,梁仁.麻杏石甘汤的现代药理研究及临床应用[J].广东药学院学报,2004,20(5)： 545-546
7.李海涛,王丁臻.老年肺炎临床特点与X线分析[J].实用医技杂志,1999,6(12)：931
8.胡东红.老年肺炎的临床及X线诊断[J].中华医学写作杂志.2000.7(3)：271
9.张梁,黄涵,周娜,等CRP、WBC及红细胞沉降率在老年肺部感染中的临床价值[J].检验医学与临床.2009,6(22)：1939-1940
1.Taooka Y, Maeda A, Hiyama K, et al.Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice[J].AM J Respi Crit Care Med,1997,156(1):260-265
2.丁彦青.严重急性呼吸综合征的病理学及发病机制[J].解放军医学杂.2003,28(6)：475-476
3.Adamson IY.Pulmonary toxicity of bleomycin[J]. Environ Health Perspect.1976,16,119-25
4.茹永新,张伯礼.红景天对博莱霉素诱导的大鼠肺损伤干预作用实验研究[J].天津中医药大学2004年博士论文：376-411
5.张秋金,沈洪,张维,等.纳洛酮与甲基泼尼松龙联用对急性肺损伤大鼠肺组织核转录因子-κB水平的影响[J].中国危重病急救医学,2005,17(6)： 370-372
6.Goodman RB, Pugin J, Lee JS, et al. Cytokine-mediated inflamma-tion in acute lung injury[J].CytokineGrowth FactorRev,2003,14(6):523-535
7.戴甜,曹书华.细胞因子在急性肺损伤／急性呼吸窘迫综合征中的作用[J].医学综述.2008.14(6)：900-902
8.Szapiel SV, Elson NA, Fulmer JD, et al.Bleomycin-induced interstitial pulmonary disease in the nude [J], athymic mouse.Am Rev Respir Dis,1979,120:893-899.
9.王浩凌,谢敏等.γ-干扰素对博莱霉素诱导的大鼠肺纤维化的干预作用[J].中国呼吸与危重监护杂志,2007,6(2)：105-109
10.程晓明,张彦琦,钱桂生.细菌感染在急性肺损伤／急性呼吸窘迫综合征中的作用[J].第三军医大学学报,2004,26(10)：848-851
11.赵静,王献华,吴秀珍等.核因子NF-κB与肺纤维化[J].中国煤炭工业医学杂志,2006,9(6)：540-542
12.徐芳,徐启勇,叶燕青.ERK信号通路在肺纤维化大鼠中的研究[J].武汉大学学报(医学版),2005,26(3)：322-325
13.徐芳,徐启勇,叶燕青.ERK信号通路与肺纤维化中细胞因子相互关系的研究[J].国外医学呼吸系统分册,2005,25(5)：334-336
2. Riqueleme R, Torres A, ElEbiary M, et al.Commuinity Acquired pneumonia in the elderly:a multivariate analysis Of Risk and prognostic factors[J]. Am. J. Respir. Crit. Care. Med,1996,154: 14502-14505
3. Marrie TJ, Blanchard W. Acomparison of nursing home Acquired pneumonia and nursing home patients without pneumonia[J]J Am Geriatr Soc,1997,45:50-551
4.陈灏珠.实用内科学第12版[M].北京：人民卫生出版社：2005：1672-1674
5.张清,郑艳,郑承铎等.加味麻杏石甘汤治疗老年肺炎48例[J].现代医药卫生,2005,21(13)：1171-1172
6.王守富.中医药治疗老年肺炎的思路与方法[J].中医研究,2008,21(3)：10-12
7.万毅,黄坤强,苏博.中西医结合诊治老年肺炎相关问题的思考[J].北京中医药大学学报(中医临床版),2008,15(1)：44-46
8.孙业敏,魏蕾,郑林.中西医结合治疗老年肺炎77例[J].山东中医杂志,2005,24(4)：232-233
9.王丰.清肺汤治疗老年肺炎69例[J].实用中医内科杂志,2008,22(7)：25
10.郭琳.清肺养阴汤治疗老年肺炎60例临床观察[J].吉林中医药,2008,28(4)：270
11.崔巍.老年肺炎的中医治疗体会[J].中国社区医师,2006,8(16)：71
12.殷凯生.老年社区获得性肺炎诊断与治疗[J].实用老年医学,2004,18(1)：7-10
13.李茹,宫晓燕.青蒿鳖甲汤治疗老年社区获得性肺炎30例疗效观察[J].长春中医药大学学报,2008,24(3)：297
14.刘君英,刘鹏鹰.老年2型糖尿病患者合并肺炎的临床分析[J].医学研究杂志,2008,37(1)：86-88
15.王秀香,杨敬平,卜宝英.老年COPD并社区获得性肺炎常见病原菌及耐药性分析[J].临床肺科杂志,2008,13(4)：426-427
16.李国梁.不同宿疾罹患老年风温肺热病后传变特点探讨[J].中国中医基础医学杂志,2008,14(10)：786-787
17.王洋,王裕颐.中西医结合治疗老年肺炎思路探讨指导[J].光明中医,2005,20(3)：10-12
18.张清,郑艳,郑承铎.加味麻杏石甘汤治疗老年肺炎48例[J].现代医药卫生,2005,21(13)：1711-1712
19.符文明,从湿温论治老年真菌性肺炎38例[J].实用中西医结合临床,2008,8(1)：73-74
20.刘良丽,欧江琴,张葵等.清肺汤合参麦注射液治疗老年真菌肺炎25例[J].贵阳中医学院学报,2006,28(4)：11-12
21.朱均权.养阴清肺化痰汤治疗老年肺炎41例[J].江西中医药,2004,10(10)：29-30
22.李喜顺,洪永贵.益气清热法治疗老年肺炎的临床观察[J].光明中医,2007,22(10)：53-54
23.林军梅.扶正清肺汤治疗医院获得性老年肺炎33例临床观察[J].浙江中医杂志,2007,42(5)：268
24.李晓霞,李丽芳,薛华.参芪扶正注射液联合特定电磁波治疗老年肺炎临床分析[J].中国临床医生,2004,32(12)：36-37
25.欧江琴,周泽桂,刘良丽.参芪扶正注射液治疗老年肺炎临床观察[J].贵阳中医学院学报,2006,28(1)：27-28
26.崔健,鲍红荣.大蒜素注射液佐治社区获得性肺炎老年患者的疗效观察[J].中国现代应用药学杂志,2006,23(5)：423-425
27.叶玲,洪旭初,陈沁.灯盏细辛注射液佐治老年社区获得性肺炎36例[J].广东医学,2005,26(6)：862-863
28.姚亮,宋文宝,杨佩兰.黄芪注射液佐治老年肺炎疗效观察[J].河南中医,2004,24(11)：33-34
29.李淑云,洪渌.清开灵注射液治疗老年细菌性肺炎30例临床观察[J].中医药临床杂志,2004,16(4)：309-310
30.肖新建,曲立生.双黄连注射液为主治疗老年肺炎32例[J].中国中医急症,2008,17(4)：491
31.陈云凤,刘洪,扈晓宇.痰热清治疗老年社区获得性肺炎临床观察[J].中国中医急症,2006,15(6)：575-587
32.张杰敏,马汉伟.痰热清注射液对老年脑卒中并发肺炎的疗效观察[J].吉林医学学报,2005,26(12)：1336-1337
33.杨雪梅.痰热清注射液治疗老年肺炎36例[J].中国中医急症,2008,17(7)：990
34.贾建华.痰热清注射液治疗老年肺炎疗效观察[J].临床肺科杂志,2007,12(2)：135
35.潘英萍.鱼金注射液联合抗生素治疗老年肺炎疗效观察[J].实用中医药杂志,2006,22(8)：487
36.古立新,梁爱武,陈斯宁等.补肺片辅助治疗老年重症肺炎时的细胞免疫功能观察[J].医学文选,2006,25(4)：699-700
37.马培志,马利军,李建生.毒素清对老年肺炎患者免疫功能的影响[J].中国老年学杂志,2006,26(1)：119-120
38.管月帆.黄芪注射液辅助治疗老年肺炎时细胞免疫功能观察[J].中国老年保健医学杂志,2007,5(2)：41-42
39.姚亮,宋文宝,杨佩兰.黄芪注射液佐治老年肺炎疗效观察[J].河南中医,2004,24(11)：33-34
40.李玉英.细菌性肺炎的治疗进展[J].泸州医学院学报,2000,(5)：423
41.程克文,马佳韵,李明珠,张有志,周丽,付明明.老年人社区获得性肺炎临床分析[J].中国临床医学.2009,16(5)：722-724
42.李树强,115例老年肺炎临床分析[J].中国医药指南.2008,6(15)：235-236
43.闫晗,刘淑华,杜密稳等.王顺老年肺炎的危险因素与病原学特点及其治疗分析[J].中国临床药理学与治疗学.2009,14(1)：94-97
44.陆卫东,张斌,曲娜等.老年患者医院获得性肺炎菌群分类及耐药性分析[J].同济大学学报(医学版).2008,29(3)：104-107
45.李琼,彭喜松.258株铜绿假单胞菌耐药性分析[J].中国感染控制杂志,2007,6(3),53-54
46.汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5)：289-295
47.朱德妹,汪复,张婴元.2005年上海地区细菌耐药性监测[J].中国感染与化疗杂志,2006,6(6)：371-376
48.Wunderink RG, Rello J, Cammarata SK. et a.l Linezolidvs vancomycin analysis of two double-blind studies of patients with methicillin resistant Staphylococcus aureus nosocomial pneumonia [J]. Chest,2003, 124(5):1789-1797
49.胡必杰.实用内科学[M].北京：人民卫生出版社,2006
50.徐胜艳.老年肺部感染临床分析[J].中外医疗.2009,15：37
1.周文泉,李祥国主编[M].实用中医老年病学.人民卫生出版社：北京,2000：12-22
2.夏云阶,张韬玉,刘汴生,等.衰老与抗衰老学[M].北京：学苑出版社,2001：1-83
3.陈庆生,瞿唯凯.94例90岁以上健康老年人五脏功能的初步分析[J].浙江中医杂志,1987,20(2)：75
4.李凯利,王晓锋.老年科常见病的诊断与治疗[M].中国医药科技出版社：北京,1999：1-12
5.周文泉,李祥国主编.实用中医老年病学[M].人民卫生出版社：北京,2000：394-395；171-274
6.尚冰.从中医角度对肝与衰老关系的浅析[J].中医药学刊.2005,23(12)：2226-2227
7.王玉芳,路永超.试论肝与衰老的关系[J].山东中医药大学学报,2002,26(4)：249-251
8.盛增秀.王孟英医学全书·王孟英医案[M].北京：中国中医药出版社,1999：279
9.何廉臣.重订广温热论[M].北京：人民卫生出版社,1960：751
10.乔振纲,韩冠先主编.实用中医痰病证治[M].人民卫生出版社：北京,2001：9
11.曲妮妮.马智教授从痰论治肺系病证经验[J].中医药学刊,2006,24(1)：26-27
12.高岩.101例老年肺炎的临床特点与治疗体会[J].中国医药导报.2008,5(8)：117-118
13.陈林果,钟玉全.152例老年社区获得性肺炎临床特征分析[J].内蒙古中医药.2008,3：1-2
14.吕和平,任爱红,郝春杰等.老年人动态肺功能与衰老的关系[J].华北煤炭医学院学报,2005,7(1)：13-14
15.黄敏,夏向南.老年脑血管病并发肺部感染的防治[J].解放军保健医学杂志.2006,8(1)：40-41
16.吴济建,朱伟芬.老年痴呆后肺部感染中医和西医治疗的成本分析[J].现代中西医结合杂志.2008,17(28)：4419
17.刘君英,刘鹏鹰.老年2型糖尿病患者合并肺炎的临床分析[J].医学研究杂志.2008,37(1)：86-88
18.张茂林,张六通,邱幸凡.中医学衰老理论探讨[J].湖北中医杂志,2001,23(9)：9-11
19.王进,张羽中,邱少波.理论研究心藏象与衰老相关性研究[J].中医药信息.2006,23(6)：1-2
20.都全荣,曹忠义,杨佰华.老年慢性肺心病血液流变性改变与活血化瘀治疗效应临床研究[J].中国血液流变学杂志,2001,11(3)：242-245
21.许朝被,王忆勤.瘀血与肺相关论[J].新中医.2009,41(2)：7-8
22.郭利平SARS的中医药分期辨治[C].国家中医药管理局编,中医药防治SARS学术专辑,2003
23.贾彦焘.40例SARS症状观察与病机探讨[C].国家中医药管理局编,中医药防治SARS学术专辑,2003
24.王永炎.严重急性呼吸综合征证治浅析[C].国家中医药管理局编,中医药防治SARS学术专辑,2003
25.张伯礼.非典的中医病名、病机及治疗[C].国家中医药管理局编,中医药防治SARS学术专辑,2003
26.彭锦,刘洋.对SARS瘀阻肺络病机的探讨[J].中国中医基础医学杂志,2003,9(12)：16-17
27.苏峥.灯盏细辛注射液治疗肺系疾病血瘀型临床观察[J].广东医学,2003,24(1)：81
28.杨进.温病学[M].中国中医药出版社：北京2004：102
29.崔巍.老年性肺炎的中医治疗体会[J].中国社区医师.2006,8(16)：71
30.万毅,黄坤强,苏博.中西医结合诊治老年肺炎相关问题的思考[J].北京中医药大学学报(中医临床版),2008,15(1)：45-46
31.杨安林,路云霞.老年慢支合并肺炎的中医药治疗体会[J].中国社区医师.2008,10(184)：79-80
32.王仰宗,苏玲.热病理论在新发传染病中的应用—-人禽流感的辨证施治[J].中国中西医结合杂志,2007,20：3
33.徐金富,瞿介明,何礼贤.肺部感染相关急性肺损伤发病机制研究进展[J].国际呼吸杂志,2008,12
34.赵勤萍.肺间质纤维化中医证治探讨[J].山西中医学院学报,2005,6(1)：34-35
35.龚婕宁.中医药治疗肺间质纤维化的概况及展望[J].浙江中医杂志,1997,32(11)：483
36.龚婕宁.论肺纤维化与养肺活血法[J].中国中医基础医学杂志,2005,11(10)：759-761
37.李士懋,田淑霄.宣展气机解郁透邪为治疗温病之要义—学习赵绍琴老师阐发温病理论的心得[J].河南中医.1998,2：2-3
38.欧阳忠兴,柯新桥.中医呼吸病学[M].中国医药科技出版社.49
39.杨进.温病学[M].中国中医药出版社：北京.2004：103-110
40.唐彦,何平.蒲辅周辨治小儿腺病毒肺炎经验撷要[J],江苏中医药,2005,26(2)：13-14
41.王新华.历代医论精选[M].江苏：江苏科学技术出版社,1998：410
42.陆拯.近代中医珍本集·温热经纬[M].杭州：浙江科学技术出版社,1987：251
43.何廉臣.重订广温热论[M].北京：人民卫生出版社,1960：6
44.吴鞠通.温病条辨[M].北京：人民卫生出版社,1963：99
45.韩德军,王松.老年肺炎108例临床分析[J].中国现代医生.2009,47(15)：137-142
46.陈红,李小惠.老年肺炎临床特点分析[J].实用医院临床杂志.2008,5(6)：104-105
47.王守富.中医药治疗老年人肺炎的思路与方法[J].中医研究.2008,21(3)：10-12
48.于雪峰.清肺涤痰颗粒佐治老年吸入性肺炎35例临床分析[J].中国中医药信息杂志,2008,15(4)：77-78
49.中华医学会呼吸病学分会.社区获得性肺炎诊断和治疗指南[J].中华呼吸和结核杂志2006,29(10)：651-655
50.李忠。免疫中药学[M].郑州,河南医科大学出版社,1996：450
51.龚婕宁,王灿晖,沈凤阁.清肺活血法运用规律析要[J].江苏中医,1997,18(7)：28-29
52.王竹修.风温肺热病99例临床疗效观察[J].中医急症通讯,1988;(10)：8
53.黄英志.叶天士医学全书.临证指南医案[M].北京：中国中医药出版社,1999：44
54.郭琳,清肺养阴汤治疗老年肺炎60例临床观察[J].吉林中医药,2008,28(4)：270
55.何牧,宫晓燕.新宣白承气汤治疗风温肺热病的临床观察[J].长春中医药大学学报.2008,24(1)：75
56.谢恬,凌一揆.清瘟败毒饮对内毒素诱发家兔温病气血两燔证的疗效和机理[J].中国中西医结合杂志,1993,13(2)：94-97
57.江扬清主编.中西医结合内科研究[M].北京：北京出版社,1997：180
1.中华医学会呼吸病学分会.社区获得性肺炎诊断和治疗指南[J].中华呼吸和结核杂志,2006,29(10)：651-655
2.国家中医药管理局.中医病证诊断疗效标准[M].南京大学出版社.1994,6,28
3.杨进主编.温病学.人民卫生出版社
4.喻庆云,朱庄庄,曹云凯.老年人肺部感染的临床特点和治疗策略[J].中国老年保健医学杂志,2005,3(2)： 17-19
5.刘晓晴,黄骁燕,陈茹.综合医院住院老年肺炎临床特点的分析[J].中华老年医学杂志,2004,23(7)：510
6.陈娜,梁仁.麻杏石甘汤的现代药理研究及临床应用[J].广东药学院学报,2004,20(5)： 545-546
7.李海涛,王丁臻.老年肺炎临床特点与X线分析[J].实用医技杂志,1999,6(12)：931
8.胡东红.老年肺炎的临床及X线诊断[J].中华医学写作杂志.2000.7(3)：271
9.张梁,黄涵,周娜,等CRP、WBC及红细胞沉降率在老年肺部感染中的临床价值[J].检验医学与临床.2009,6(22)：1939-1940
1.Taooka Y, Maeda A, Hiyama K, et al.Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice[J].AM J Respi Crit Care Med,1997,156(1):260-265
2.丁彦青.严重急性呼吸综合征的病理学及发病机制[J].解放军医学杂.2003,28(6)：475-476
3.Adamson IY.Pulmonary toxicity of bleomycin[J]. Environ Health Perspect.1976,16,119-25
4.茹永新,张伯礼.红景天对博莱霉素诱导的大鼠肺损伤干预作用实验研究[J].天津中医药大学2004年博士论文：376-411
5.张秋金,沈洪,张维,等.纳洛酮与甲基泼尼松龙联用对急性肺损伤大鼠肺组织核转录因子-κB水平的影响[J].中国危重病急救医学,2005,17(6)： 370-372
6.Goodman RB, Pugin J, Lee JS, et al. Cytokine-mediated inflamma-tion in acute lung injury[J].CytokineGrowth FactorRev,2003,14(6):523-535
7.戴甜,曹书华.细胞因子在急性肺损伤／急性呼吸窘迫综合征中的作用[J].医学综述.2008.14(6)：900-902
8.Szapiel SV, Elson NA, Fulmer JD, et al.Bleomycin-induced interstitial pulmonary disease in the nude [J], athymic mouse.Am Rev Respir Dis,1979,120:893-899.
9.王浩凌,谢敏等.γ-干扰素对博莱霉素诱导的大鼠肺纤维化的干预作用[J].中国呼吸与危重监护杂志,2007,6(2)：105-109
10.程晓明,张彦琦,钱桂生.细菌感染在急性肺损伤／急性呼吸窘迫综合征中的作用[J].第三军医大学学报,2004,26(10)：848-851
11.赵静,王献华,吴秀珍等.核因子NF-κB与肺纤维化[J].中国煤炭工业医学杂志,2006,9(6)：540-542
12.徐芳,徐启勇,叶燕青.ERK信号通路在肺纤维化大鼠中的研究[J].武汉大学学报(医学版),2005,26(3)：322-325
13.徐芳,徐启勇,叶燕青.ERK信号通路与肺纤维化中细胞因子相互关系的研究[J].国外医学呼吸系统分册,2005,25(5)：334-336